Re: A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma

J Urol. 2018 Jan;199(1):23-25. doi: 10.1016/j.juro.2017.09.134. Epub 2017 Oct 10.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Renal Cell*
  • Humans
  • Kidney Neoplasms
  • Pyrroles
  • Sunitinib*

Substances

  • Pyrroles
  • Sunitinib